ZhouY, HuW, ZhuangW, Vascular endothelial growth factor (VEGF) +936 C/T gene polymorphisms and gastric cancer risk: a meta-analysis involving 4,138 subjects. Int J Biol Markers2010; 25: 213–8.
2.
KeQ, LiangJ, WangLN, Potentially functional polymorphisms of the vascular endothelial growth factor gene and risk of gastric cancer. Mol Carcinog2008; 47: 647–51.
3.
LiberatiA, AltmanDG, TetzlaffJ, ThePR. SMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration. BMJ2009; 339: b2700.
4.
BaeSJ, AhnDH, HongSP, Gender-specific association between polymorphism of vascular endothelial growth factor (VEGF 936C>T) gene and patients with stomach cancer. Yonsei Med J2008; 49: 783–91.
5.
WatsonCJ, WebbNJ, BottomleyMJ, BrenchleyPE. Identification of polymorphisms within the vascular endothelial growth factor (VEGF) gene: correlation with variation in VEGF protein production. Cytokine2000; 12: 1232–5.
6.
BaeSJ, KimJW, KangH, HwangSG, OhD, KimNK. Gender-specific association between polymorphism of vascular endothelial growth factor (VEGF 936 C>T) gene and colon cancer in Korea. Anticancer Res2008; 28: 1271–6.
7.
KripplP, LangsenlehnerU, RennerW, A common 936 C/T gene polymorphism of vascular endothelial growth factor is associated with decreased breast cancer risk. Int J Cancer2003; 106: 468–71.
8.
TepesB.Can gastric cancer be prevented?J Physiol Pharmacol2009; 60: 71–7.
